Smith Group Asset Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-5,160
| Closed | -$682K | – | 449 |
|
|
2018
Q2 | $682K | Buy |
5,160
+100
| +2% | +$13.2K | 0.02% | 192 |
|
|
2018
Q1 | $375K | Sell |
5,060
-4,100
| -45% | -$304K | 0.01% | 206 |
|
|
2017
Q4 | $510K | Hold |
9,160
| – | – | 0.02% | 211 |
|
|
2017
Q3 | $415K | Hold |
9,160
| – | – | 0.01% | 228 |
|
|
2017
Q2 | $309K | Sell |
9,160
-100
| -1% | -$3.37K | 0.01% | 244 |
|
|
2017
Q1 | $274K | Hold |
9,260
| – | – | 0.01% | 234 |
|
|
2016
Q4 | $254K | Buy |
+9,260
| New | +$254K | 0.01% | 234 |
|